The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query MYMD owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/MYMD"
Use Arkolith to show who owns MYMD, which funds added or reduced it, and which SEC filings prove each claim.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 24, 2023 | Rivard Paul | Chief Legal Officer | Buy (P) | 150K | $167K |
| Aug 17, 2023 | Rivard Paul | Chief Legal Officer | Buy (P) | 25K | $28K |
| Jun 7, 2023 | Kaplin Adam | Chief Scientific Officer | Grant (A) | 150K | $0 |
| Jun 7, 2023 | White Billy Joe | Director | Grant (A) | 150K | $0 |
| Jun 7, 2023 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant (A) | 300K | $0 |
| Jun 7, 2023 | Schreiber Christopher C | Director | Grant (A) | 150K | $0 |
| Jun 7, 2023 | EAGLE CRAIG | Director | Grant (A) | 475K | $0 |
| Jun 7, 2023 | Silverman Joshua | Director | Grant (A) | 200K | $0 |
| Jun 7, 2023 | Uzonwanne Jude | Director | Grant (A) | 150K | $0 |
| Jun 7, 2023 | Rivard Paul | Chief Legal Officer | Grant (A) | 150K | $0 |
| Apr 4, 2023 | Chapman Christopher C JR | President, Chief Med. Officer, Director | Grant (A) | 750K | $0 |
| Dec 8, 2022 | Rivard Paul | EVP of Operations, GC | Buy (P) | 10K | $15K |
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for MYMD. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.